Characterization of the diarylether sulfonylester (−)-(R)-3-(2-hydroxymethylindanyl-4-oxy) phenyl-4, 4, 4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid …

F Mauler, J Mittendorf, E Horváth, J De Vry - Journal of Pharmacology and …, 2002 - ASPET
(−)-(R)-3-(2-Hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271)
is a new high-affinity cannabinoid receptor subtype 1 (CB1 receptor) ligand (K i = 0.46–1.85 …

4-Phenyl-4H-pyrans as IKCa channel blockers

K Urbahns, E Horváth, JP Stasch, F Mauler - Bioorganic & medicinal …, 2003 - Elsevier
4-Phenyl-4H-pyrans have been identified as potent and specific IK Ca channel blockers.
Their synthesis and structure–activity relationships are described. A selected derivative, rac-11, …

Selective intermediate‐/small‐conductance calcium‐activated potassium channel (KCNN4) blockers are potent and effective therapeutics in experimental brain …

F Mauler, V Hinz, E Horváth… - European Journal of …, 2004 - Wiley Online Library
Early deterioration and death after brain injury is often the result of oedema in the injured and
peri‐lesional tissue. So far, no pharmacotherapy is available that exhibits significant brain …

A synthetic derivative of the natural product rocaglaol is a potent inhibitor of cytokine-mediated signaling and shows neuroprotective activity in vitro and in animal …

T Fahrig, I Gerlach, E Horvath - Molecular pharmacology, 2005 - ASPET
Many acute and chronic neurodegenerative diseases are characterized by a localized
inflammatory response and constitutive activation of the transcription factors nuclear factor-κB (NF-…

Inhibition of evoked glutamate release by the neuroprotective 5-HT1A receptor agonist BAY x 3702 in vitro and in vivo

F Mauler, T Fahrig, E Horváth, R Jork - Brain research, 2001 - Elsevier
Brain ischemia provoked by stroke or traumatic brain injury induces a massive increase in
neurotransmitter release, in particular of the excitotoxin glutamate. Glutamate triggers a …

Neuroprotective and brain edema-reducing efficacy of the novel cannabinoid receptor agonist BAY 38-7271

…, V Hinz, KH Augstein, M Faßbender, E Horváth - Brain research, 2003 - Elsevier
BAY 38-7271 is a new high-affinity cannabinoid receptor agonist with strong neuroprotective
efficacy in a rat model of traumatic brain injury (acute subdural hematoma, SDH). In the …

Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu1 receptor antagonist BAY 36-7620

J De Vry, E Horváth, R Schreiber - European journal of pharmacology, 2001 - Elsevier
This study characterized the neuroprotective and behavioral effects of (3aS,6aS)-6a-naphtalen-2-ylmethyl-5-methyliden-hexahydro-cyclopenta[c]furan-1-on
(BAY 36-7620), a novel, …

Neuroprotective Efficacy of Repinotan HCl, a 5-HT1A Receptor Agonist, in Animal Models of Stroke and Traumatic Brain Injury

F Mauler, E Horváth - Journal of Cerebral Blood Flow & …, 2005 - journals.sagepub.com
Repinotan is a highly potent 5-HT 1A receptor agonist with strong neuroprotective efficacy
in animal models of middle cerebral artery occlusion and traumatic brain injury. In this study, …

IKCa-channel blockers. Part 2: discovery of cyclohexadienes

K Urbahns, S Goldmann, J Krüger, E Horváth… - Bioorganic & medicinal …, 2005 - Elsevier
Novel cyclohexadienes have been identified as potent and specific IK Ca -channel blockers.
In this communication we describe their synthesis as well as their chemical and biological …

BAY 38–7271: a novel highly selective and highly potent cannabinoid receptor agonist for the treatment of traumatic brain injury

F Mauler, E Horváth, J De Vry, R Jäger… - CNS Drug …, 2003 - Wiley Online Library
Traumatic brain injury (TBI) is the most common cause of mortality and morbidity in adults
under 40 years of age in industrialized countries. Worldwide the incidence is increasing, about …